CDC works closely with state and local public health departments, travel industry partners, and others to identify and test people who may be infected with MERS-CoV. CDC conducts several different laboratory tests to detect MERS-CoV infection.
In general, these lab tests fall into two categories:
- Molecular tests, which look for evidence of active infection; and
- Serology tests, which look for previous infection by detecting antibodies to MERS-CoV. Serology tests are for surveillance or investigational purposes and not for diagnostic purposes.